Key statistics · As on 15 Oct 2026
Market cap
BDT 1,296.750 mn
Free float market cap
BDT 710.444 mn
NAV per share
BDT 15.48
P/E (audited)
—
Day's value
BDT 3.21 mn
Day's volume
329,389
Day's trades
250
Opening price
BDT 9.50
Adjusted Opening Price
BDT 9.50
Yesterday's closing price
BDT 9.50
Closing price
BDT 9.80
Last Update
2:09 PM
Day's range
Current BDT 9.80
BDT 9.50BDT 9.90
52-week range
Current BDT 9.80
BDT 7.60BDT 14.40
Basics
- Listing year
- 2018
- Authorized Capital (mn)
- BDT 1,500
- Paid-up capital
- BDT 1,365.00 mn
- Face value
- BDT 10.00
- Total outstanding securities
- 136,500,000
- Market Lot
- 1
Shareholding pattern
as on Jun 30, 2025 (year ended)
as on Dec 31, 2025
as on Jan 31, 2026
Sponsor / Director
45.21%
45.21%
45.21%
Government
0.00%
0.00%
0.00%
Institution
16.84%
16.07%
16.05%
Foreign
0.01%
0.01%
0.01%
Public
37.94%
38.71%
38.73%
Shareholding percentages as reported by the listed company.
Sponsor/Director holdings reflect regulation 2(1)(r) of the DSE (Listing) Regulations 2015.
Corporate & contact
- Present Operational Status
- Active
- Head Office / Registered Office
- House # 65, Road # 8/A (New), Dhanmondi, Dhaka-1209.
- Factory Address
- Joykrishnapur, Main Road, Maijdee Court, Noakhali.
- Contact Phone
- +88-02-55000692, +88-02-55000952
- Fax
- +88-02-55000693
- share@silvapharma.com
- Company Secretary Name
- Md. Iqbal Hossain
- Company Secretary Cell No.
- 01711891686
- Company Secretary Telephone No.
- +88-02-9146009-205
- Company Secretary E-mail
- hossainiqbal.md123@gmail.com
- Website
- www.silvapharma.com
- Loan status
- Short-term: BDT 28.22 mn · Long-term: BDT 0 mn
- Present Loan Status — as on
- —
- Credit rating
- Short-term: — · Long-term: —
- Last AGM
- 30-12-2025
- Year-end
- June
Details of Financial StatementAnnual Reports – Silva Pharmaceuticals Ltd.
Price Sensitive Informationhttp://Price Sensitive Information – Silva Pharmaceuticals Ltd.